CME Group Analyst Price Targets - Benzinga

CME Group Inc

CMENASDAQ

Trade with Public

Trade with Public

$280.56

4.121.49%

Dern. MÀJ: Oct 9, 4:55 PM

$280.58

4.141.5%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

CME Group Analyst Price Targets - Benzinga

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 10 Quarters

Analyst Consensus — 18 Analysts

9Buy

6Hold

3Sell

Consensus RatingOutperform# Analysts18Avg. Consensus PT$282Upside to Avg. PT+0.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	Morgan Stanley	Michael Cyprys	PT Raise	Overweight	$330→$337
Oct 7, 2026	Barclays	Benjamin Budish	PT Raise	Equal-Weight	$270→$281
Oct 5, 2026	UBS	Alex Kramm	PT Raise	Neutral	$260→$270
Oct 5, 2026	TD Cowen	Bill Katz	PT Raise	Buy	$292→$300
Oct 2, 2026	Wells Fargo	Daniel Welden	Initiate	Overweight	$301
Sep 28, 2026	TD Cowen	Bill Katz	Maintained	Buy	$292
Sep 3, 2026	TD Cowen	Bill Katz	Maintained	Buy	$292
Aug 19, 2026	Deutsche Bank	Brian Bedell	Downgrade	Buy→Hold	$286→$270
Jul 23, 2026	JP Morgan	Kenneth Worthington	PT Raise	Underweight	$249→$250
Jul 23, 2026	B of A Securities	Craig Siegenthaler	PT Raise	Underperform	$226→$230
Jul 23, 2026	Morgan Stanley	Michael Cyprys	PT Raise	Overweight	$324→$330
Jul 15, 2026	Piper Sandler	Patrick Moley	PT Cut	Overweight	$329→$295
Jul 10, 2026	Morgan Stanley	Michael Cyprys	PT Cut	Overweight	$353→$324
Jul 9, 2026	Barclays	Benjamin Budish	PT Cut	Equal-Weight	$316→$270
Jul 8, 2026	TD Cowen	Bill Katz	PT Cut	Buy	$273→$270
Jul 6, 2026	UBS	Alex Kramm	PT Cut	Neutral	$310→$260
Jul 2, 2026	Raymond James	Patrick O'Shaughnessy	Maintained	Outperform	$320
Jun 22, 2026	TD Cowen	Bill Katz	PT Cut	Buy	$323→$273
Jun 18, 2026	Keefe, Bruyette & Woods	Chris Allen	Upgrade	Market Perform→Outperform	$305
Jun 11, 2026	Rothschild & Co	Simon Clinch	Upgrade	Neutral→Buy	$316→$323

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $337

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $330 to $337.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $281

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $270 to $281.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on CME Group, Raises Price Target to $270

UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on CME Group, Raises Price Target to $300

TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.

Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On CME Group with Overweight Rating, Announces Price Target of $301

Wells Fargo analyst Daniel Welden initiates coverage on CME Group (NASDAQ:CME) with a Overweight rating and announces Price Target of $301.

Benzinga Newsdesk

PRO
TD Cowen Reiterates Buy on CME Group, Maintains $292 Price Target

TD Cowen analyst Bill Katz reiterates CME Group (NASDAQ:CME) with a Buy and maintains $292 price target.

Benzinga Newsdesk